CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Timna Naftali

OPENALEX: A5033531513↗ORCID: 0000-0002-8931-6524↗

Affiliations

Organizations

Clalit Health Servicesauthorship · IL Meir Medical Centerauthorship · IL Tel Aviv Universityauthorship · IL

Public evidence

4 connected articles

Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study.2022 · Europe PMC Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.2021 · PubMed Central Open Access Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption.2021 · Europe PMC Cannabis for the Treatment of Inflammatory Bowel Disease: A True Medicine or a False Promise?2020 · PubMed Central Open Access

Registered research

Connected studies

A Double Blind Placebo Controlled Study of Cannabis Smoking in Inflammatory Bowel Diseasenct01040910

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Timna Naftali - Medical Cannabis Research Engine